Monday, August 3, 2015   

GSK to sell oncology arm to Novartis
(04-22 14:22)

British pharmaceutical giant GlaxoSmithKline is to sell its oncology business to peer Novartis for US$16 billion and to buy the Swiss company's vaccines division, GSK announced on Tuesday.
Under a "major three-part transaction'' GSK and Novartis have agreed also to create a consumer healthcare business, according to a statement issued by GlaxoSmithKline. --AFP
   
Other Business breaking news:
Russia's central bank cuts interest rate to 11 percent (07-31 20:11)
European stocks mixed (07-31 20:10)
(Greece crisis) Tsipras admits secret plan on eurozone exit (07-31 18:07)
Swiss central bank takes 50b franc hit (07-31 17:38)
Eurozone inflation steady, jobless rate unchanged (07-31 17:10)
Positive close for Hang Seng, Shanghai drops (07-31 17:03)
Dassault stake sale fattens Airbus reports to 1.5b euros (07-31 15:56)
Nikkei closes higher (07-31 14:30)
Honda earnings rise (07-31 14:29)
Sharp losses worsen to US$274m (07-31 14:26)

More breaking news >>

© 2015 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2015, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.